A novel TanCAR targeting IL13Rα2 and EphA2 for enhanced glioblastoma therapy.
Muhammad N, Wang R, Li W, Zhang Z, Chang Y, Hu Y, Zhao J, Zheng X, Mao Q, Xia H.
Muhammad N, et al. Among authors: li w.
Mol Ther Oncolytics. 2022 Feb 20;24:729-741. doi: 10.1016/j.omto.2022.02.012. eCollection 2022 Mar 17.
Mol Ther Oncolytics. 2022.
PMID: 35317513
Free PMC article.